Macrogenics (MGNX) Net Margin Growth (1y) (2013 - 2026)
Macrogenics (MGNX) Net Margin Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,491.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,120.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -653.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 447.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Macrogenics | 254.43 Mn | 187.92 Mn | - | 13,651.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13,651.00 |
| Dec 31, 2025 | 429.00 |
| Sep 30, 2025 | -2,777.00 |
| Jun 30, 2025 | 35,256.00 |
| Mar 31, 2025 | 77,677.00 |
| Dec 31, 2024 | 42,184.00 |
| Sep 30, 2024 | 39,233.00 |
| Jun 30, 2024 | -15,734.00 |
| Mar 31, 2024 | -91,174.00 |
| Dec 31, 2023 | -47,678.00 |
| Sep 30, 2023 | -28,167.00 |
| Jun 30, 2023 | -19,746.00 |
| Mar 31, 2023 | 41,961.00 |
| Dec 31, 2022 | 274,367.00 |
| Sep 30, 2022 | 40,574.00 |
| Jun 30, 2022 | 14,554.00 |
| Mar 31, 2022 | 23,934.00 |
| Dec 31, 2021 | -139,943.00 |
| Sep 30, 2021 | -5,383.00 |
| Jun 30, 2021 | 19,597.00 |